相关临床试验
151
25 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
2011
进行中（未招募）
11
7.3%
已完成
65
43.0%
尚未招募
14
9.3%
招募中
30
19.9%
终止
2
1.3%
Unknown
24
15.9%
撤回
5
3.3%
暂无批准数据
- A Phase 1 trial in 39 healthy volunteers demonstrated that an AI-designed universal Sarbeco coronavirus vaccine is safe with no significant side effects. - The vaccine, developed by the University of Cambridge and DIOSynVax, triggered immune responses against SARS-CoV-2, SARS, and related bat viruses with pandemic potential. - This marks the first time a vaccine whose active component was designed entirely by computer simulations has been tested in humans. - The technology uses a machine learning-designed "super-antigen" to provide broad protection across entire virus families, potentially eliminating the need for annual reformulation.
• An international panel of 141 clinicians from 32 countries has reached consensus supporting the use of asthma biologics during pregnancy and conception when clinically indicated and agreed upon by patients. • The consensus statement recommends that pregnant patients on asthma biologics should receive coordinated care from respiratory and obstetric teams, with treatment documented in national or international registries. • While established biologics like omalizumab show strong support, newer treatments such as tezepelumab require additional safety data, highlighting the need for continued research in this area.
